Merck

Extracted Attributes

Merck & Co.

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda (pembrolizumab), a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Web Search Results

• MRK Merck & Co., Inc.

  Merck & Co. Inc. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine

• Merck

  At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents

• Investor relations

  #### Our Q4 and full-year 2025 financial results Merck’s (NYSE: MRK) Q4 and full-year 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our company announced Q4 worldwide sales of $16.4 billion. Full-year 2025 worldwide sales were $65.0 billion. “In 2025, we continued to advance leading-edge science to deliver transformative medicines and vaccines that […] Read more Next: Our Q4 and full-year 2025 financial results ## Sign up for email alerts Receive company news, updates and other information [...] #### Our Q4 and full-year 2025 financial results Merck’s (NYSE: MRK) Q4 and full-year 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our company announced Q4 worldwide sales of $16.4 billion. Full-year 2025 worldwide sales were $65.0 billion. “In 2025, we continued to advance leading-edge science to deliver transformative medicines and vaccines that […] Read more Innovation #### Our Q2 2026 financial results [...] Innovation #### Our Q2 2026 financial results Merck’s (NYSE: MRK) Q2 2026 results reflect continued strength in oncology and animal health, plus increasing contributions from launches. Our company announced Q2 worldwide sales of $16.6 billion. “We continued to make substantial progress across our business this quarter, driven by strong execution and growing contributions from new product launches,” said Rob Davis, chairman and […] Read more Innovation #### Our Q1 2026 financial results

• We are Merck

  ### {{ userContent.lookingForMoreLabel }} # We are Merck As a vibrant science and technology company, we believe in science as a force for good. We uniquely combine three specialized, innovation-driven businesses: Life Science, Healthcare, and Electronics. ## Explore More ## Explore More ## Sparking Discovery, Elevating Humanity Our passion for science and technology drives our approximately 62,000 employees in 65 countries to address some of today’s toughest challenges and develop more sustainable ways of living. [...] In our rapidly changing and uncertain world, factors such as an aging population, chronic diseases, AI, climate change, and other megatrends have created an appetite for scientific breakthroughs that can make a positive difference across our global society. The pace of change will increase over coming decades as technologies evolve and converge in ways that fundamentally transform how we live and work. For us at Merck, change is not a threat but an opportunity as we have proven for over more than 350 years. Sparking Discovery, Elevating Humanity as our unifying vision [...] Disclaimer Image Disclaimer Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD. Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD. Select your Market EN Vibrant Science & Technology Merck is a vibrant team of specialists in Electronics, Healthcare and Life Science. We share a love of science and a passion for technology. Featured Content Digital Ethics Promo 800 600 Size 250 140 Fmt Webp Alpha Digital Ethics The Living Memory Of Merck Featured 200x150 Size 250 140 Fmt Webp Alpha History Compliance Hotline EN Size 250 140 Fmt Webp Alpha

• Merck & Co.

  Print/export Download as PDF Printable version In other projects Wikimedia Commons Wikidata item Appearance From Wikipedia, the free encyclopedia American multinational pharmaceutical company Not to be confused with the Merck Group (Merck KGaA), a distinct but historically related company based in Germany. Merck & Co., Inc. [...] In 1953, Merck & Co. merged with Philadelphia-based Sharp & Dohme, Inc., becoming the largest U.S. drugmaker. Sharp and Dohme had acquired H. K. Mulford Company in 1929, adding smallpox vaccines to its portfolio. The combined company kept the trade name Merck in the United States and Canada, and as Merck Sharp & Dohme (MSD) outside these two countries. In 1965, Merck & Co. acquired Charles Frosst Ltd. of Montreal (founded 1899), creating Merck-Frosst Canada, Inc., as its Canadian subsidiary and pharmaceutical research facility. Merck & Co. closed this facility in July 2010 but reemerged in 2011 as Merck Canada. [...] | v t e Merck family | | Merck family | Friedrich Jacob Merck Heinrich Emanuel Merck George W. Merck | | Companies | Merck (est. 1668) H. J. Merck & Co. (est. 1799) Merck & Co. (MSD) (est. 1891) | | v t e Pharmaceutical companies of the United States |

• Instance Of

  Q4167410